| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 |
| filingDate |
2010-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02df005cd60272de5fa9a9f4995e015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bb351eecca14daeb627026f0f338d54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f114d8d711baae037b5c2bc8d1eba61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42828ab4c7cdce603b4dd253c4c8321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6a1657778b299aabaa1468e366210b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e4155221377e9af382b6092f404166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a327b614e92c7ebbff463b6b093e2ccb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9a52e2a01b15e1a04ff93f9eee3c423 |
| publicationDate |
2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2548887-B1 |
| titleOfInvention |
Composition for inhibiting cancer metastasis containing dlk1-fc fusion protein as an active ingredient |
| priorityDate |
2010-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |